A novel orally-available selective orexin 2 receptor agonist, E2086, enhances wake-promotion and treats narcolepsy-like symptoms in narcolepsy model mice - Hatanaka, K; Suzuki, H; Michikawa, F (Neuropsychopharmacology, 2022)